Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18391953 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter
Condition: Heterozygous Carriers of Gitelman Syndrome
Interventions: Procedure: Blood sample;   Procedure: Urine sample;   Procedure: Blood pressure

Indicates status has not been verified in more than two years